Tissue distribution of drug-metabolizing enzymes in humans

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
G M PacificiG B Muraro

Abstract

1. The activities of the ethoxycoumarin O-deethylase (ECOD), epoxide hydrolase (EH), UDP-glucuronyl transferase (GT), glutathione S-transferase (GST), acetyl transferase (AT) and sulphotransferase (ST) were measured in 6 liver, 8 lung, 8 kidney, 8 intestinal mucosa and 22 urinary bladder mucosa specimens from human subjects. EH and GT were studied with styrene oxide and 1-naphthol, respectively, as substrates, GST, AT and ST were studied with benzo(a)pyrene-4,5-oxide, p-aminobenzoic acid and 2-naphthol, respectively. 2. The enzyme activities were detectable at significant rates in liver, lungs, kidneys and gut. In urinary bladder, EH, GT, GST and ST only were detectable. The liver catalyzed the various reactions at higher rates than did other tissues. 3. Of the extrahepatic tissues, the intestinal mucosa contained the highest activities of AT (50% of liver) and ST (30% of liver), whereas kidneys contained the highest activity of GT (50% of liver) and GST (80% of liver). GST was the enzyme with the widest tissue distribution.

References

Dec 18, 1978·European Journal of Clinical Pharmacology·K W BockD Josting
May 1, 1979·Analytical Biochemistry·R D SekuraW B Jakoby
Nov 10, 1975·Biochimica Et Biophysica Acta·B R Sonawane, G W Lucier
Jan 1, 1986·Pharmacology·G M PacificiA Rane
Jan 1, 1973·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A Aitio
Jul 1, 1981·Clinical Pharmacokinetics·C F George
Jan 1, 1981·Comparative Biochemistry and Physiology. C: Comparative Pharmacology·A J BaarsD D Breimer
Jan 1, 1980·Annals of the New York Academy of Sciences·R E McMahon
Jun 1, 1984·Biochemical Pharmacology·W L WhyteA R Buckpitt
Feb 11, 1980·Life Sciences·M E McManusD S Davies
Feb 1, 1982·Acta Pharmacologica Et Toxicologica·G M Pacifici, A Rane
May 1, 1982·Acta Pharmacologica Et Toxicologica·S W JakobssonR A Prough
Feb 1, 1981·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G M PacificiD S Davies
Jan 1, 1981·Pharmacology·H MukhtarD D Breimer

❮ Previous
Next ❯

Citations

Jan 1, 1991·Journal of Biochemical Toxicology·C W Wheeler, T M Guenthner
Jan 1, 1988·Archives of Toxicology·G M PacificiF Oesch
Aug 11, 1993·Molecular and Cellular Biochemistry·J A HypoliteR M Levin
Jan 1, 1993·Archives of Toxicology·A L MendralaR J Nolan
Jan 1, 1996·Clinical Reviews in Allergy & Immunology·T WalleG R Pesola
Jan 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·M Láznícek, A Láznícková
Jan 15, 1991·Biochemical Pharmacology·P G GervasiF Ursino
Jan 1, 1992·Pharmacology & Therapeutics·F P Guengerich
Jan 1, 1994·Pharmacology & Therapeutics·M S O'Mahony, K W Woodhouse
Jun 6, 2000·Advanced Drug Delivery Reviews·D D ShenK E Thummel
Dec 12, 2001·Toxicology Letters·Johannes G FilserGyörgy A Csanády
Feb 28, 2007·The Pharmacogenomics Journal·R H M te MorscheH Witt
Jul 1, 1999·Clinical and Experimental Pharmacology & Physiology·R N Upton, D J Doolette
Mar 13, 2003·Kidney International·Kian Hong NgKim Ping Wong
May 16, 2002·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Joshua T CohenKimberly Thompson
Aug 21, 2003·Journal of the National Cancer Institute·Yutaka TsuneokaDaniel W Nebert
Oct 22, 2005·Inflammatory Bowel Diseases·Gwo-Tzer HoJack Satsangi
Mar 1, 1996·British Journal of Clinical Pharmacology·E A EatonT Walle
May 5, 1999·Fundamental & Clinical Pharmacology·L BartheG Houin
Nov 1, 1995·British Journal of Pharmacology·J VergésP du Souich
Jan 26, 2005·Basic & Clinical Pharmacology & Toxicology·Smarajit MaitiGuangping Chen
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R H Tukey, C P Strassburg
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·J H Lin, A Y Lu
Feb 26, 2011·The European Respiratory Journal·M W ButlerR G Crystal
Nov 1, 1992·Environmental Health Perspectives·F F KadlubarN P Lang
Nov 1, 2013·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Yuesheng Zhang
Jul 16, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seho ParkSangyong Jon
Mar 29, 2014·Drug Metabolism Reviews·Ursula Gundert-RemyPeter H Roos
Jun 18, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R De KanterG M M Groothuis
Jun 12, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·V RodillaG M Hawksworth
Jan 27, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H M KorashyA O S El-Kadi
May 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M Vargas, M R Franklin
Apr 26, 2005·Journal of Biochemical and Molecular Toxicology·Smarajit MaitiGuangping Chen
Sep 8, 2004·Biochemical and Biophysical Research Communications·Smarajit MaitiGuangping Chen
Jan 14, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Diansong ZhouScott W Grimm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.